Filing Details
- Accession Number:
- 0001055726-22-000041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-17 16:32:21
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-17 16:32:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1669080 | B. David Weiner | 660 W. Germantown Pike Suite 110 Plymouth Meeting PA 19462 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-13 | 18,000 | $0.00 | 901,625 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-05-16 | 9,000 | $1.95 | 892,625 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2022-05-13 | 18,000 | $0.00 | 18,000 | $0.00 |
Common Stock | Restricted Stock Unit | Acquisiton | 2022-05-16 | 19,000 | $0.00 | 19,000 | $0.00 |
Common Stock | Common Stock Options | Acquisiton | 2022-05-16 | 28,000 | $0.00 | 28,000 | $1.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
19,000 | No | 4 | A | Direct | ||
28,000 | 2032-05-16 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
- Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
- This grant was made pursuant to the issuer's non-employee director compensation policy.
- Options to vest 100% on May 16, 2023.